Diagnostic accuracy of (18)F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP)

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update

Perceptions About Asymptomatic Hyperuricemia and Views About Urate-Lowering Therapy in People With Asymptomatic Hyperuricemia

The OMERACT core domain sets for calcium pyrophosphate deposition disease

Advanced imaging techniques in crystal arthritis

A new ex vivo human model of osteoarthritis cartilage calcification

Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

The role of renal dual-energy computed tomography in exploring the gouty kidney: the RENODECT study

Tradition Versus Innovation: Conventional Radiography and Ultrasound in Calcium Pyrophosphate Deposition Identification. Instructions for Use

Calcium pyrophosphate crystal deposition: 2025 update to recent epidemiological findings

Imaging of crystal-induced arthropathies in 2025

Current challenges in understanding the epidemiology of calcium pyrophosphate crystal deposition

Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort

Calcium pyrophosphate deposition disease

Intra-Articular Mineralization on Computerized Tomography of the Knee and Risk of Cartilage Damage: The Multicenter Osteoarthritis Study

2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice

Nothing about us without us: Sharing results with communities that provide genomic data

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

Reliability and Diagnostic Accuracy of Radiography for the Diagnosis of Calcium Pyrophosphate Deposition: Performance of the Novel Definitions Developed by an International Multidisciplinary Working Group

Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout

Gout and power: the history of five political figures shaped by the disease

Musculoskeletal ultrasound findings in people with asymptomatic hyperuricemia: baseline analysis from the Transitions in Gout Research (TIGER) study using the OMERACT gout ultrasound semiquantitative scoring system

Colchicum and gout: two millennia of therapeutic continuity

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)

Hyperuricaemia and gout in the Pacific

Are gout patients with negative dual-energy computed tomography for monosodium urate crystal deposition easy to treat?

Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states- A Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus project

Imaging in the assessment of deposits in gout: From research to daily clinical implementation

Time-course of tophus resolution on Dual-energy CT and ultrasound after 24months of a treat-to-target strategy: Results from GOUT-DECTUS study

Gout: the deeply rooted image of the self-inflicted disease of kings comes from misinterpreting history

Publisher Correction: A genome-wide association analysis reveals new pathogenic pathways in gout

A genome-wide association analysis reveals new pathogenic pathways in gout

Early-onset gout

Associations of Changes in Knee Hyaline Cartilage Composition Measured With Dual-Energy Computed Tomography in Gout, Aging and Osteoarthritis

Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohort

The gout epidemic in French Polynesia: a modelling study of data from the Ma'i u'u epidemiological survey

The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout

Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout

Prediction of renal and cardiometabolic outcomes in gout during urate-lowering therapy by sonography

Exploring Patients' Profiles Associated With the Resolution of Acute Calcium Pyrophosphate Arthritis Treated With Colchicine and Prednisone: Post Hoc Analysis of a Randomized Controlled Trial

Transcutaneous neurostimulation parameters for neuropathic radicular pain: Results from a two period crossover randomized trial

Gabapentin versus placebo for the treatment of acute lumbosacral radicular pain caused by disc herniation: study protocol of the GRADE randomized controlled double-blind superiority trial

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)

Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states- A Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus project

Pseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?-The time has come to reconsider the nomenclature of calcium pyrophosphate deposition

Exploring Patients' Profiles Associated With the Resolution of Acute Calcium Pyrophosphate Arthritis Treated With Colchicine and Prednisone: Post Hoc Analysis of a Randomized Controlled Trial

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial

Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT): an open-label, multicentre, randomised trial

Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus

Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensus

Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial

Genome-wide association study in chondrocalcinosis reveals ENPP1 as a candidate therapeutic target in calcium pyrophosphate deposition disease

Development and internal-external cross-validation of a patient-reported definition for acute calcium pyrophosphate crystal arthritis

IL-6: A new target in crystal-induced arthritides - A narrative review

Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study